Background illustration for clinical trials search

Paid Clinical Trials Norwalk

Discover 1,132 paid clinical trials in Norwalk, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

for
Relapsed Refractory Multiple Myeloma
Location: New Haven CT, New York NY, Montreal, Toronto,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07391657

Phase3, Recruiting
Active & Responsive

Transcranial Magnetic Stimulation (TMS) to Treat Depression in Autism Spectrum Disorder

for
Autism Spectrum Disorder
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18 - 40

Code: NCT06142955

Recruiting
Active & Responsive

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

for
Alzheimers Disease, Dementia, Alzheimers Disease, Familial
Location: New Haven CT, New York NY, Providence RI, Verdun,
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06647498

Phase2, Phase3, Recruiting
Active & Responsive

Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

for
Epilepsy, Epilepsy (Treatment Refractory)
Location: New Haven CT, Philadelphia PA, Boston MA, Cleveland OH,
Sponsor: Epiminder America, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07110454

Recruiting
Active & Responsive

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

for
Alzheimers Disease, Dementia, Alzheimers Disease, Familial
Location: New Haven CT, New York NY, Providence RI, Verdun,
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT05552157

Phase2, Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Off Treatment Urinary Copper Excretion in Wilson Disease, Pilot Study

for
Wilson Disease
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT07301216

Recruiting
Active & Responsive

Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

for
Surgery-Complications, Anesthesia Complication,
Location: New Haven CT, New York NY, Philadelphia PA, Boston MA,
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT05991453

Recruiting
Active & Responsive

Multi-Site Trial of Tirzepatide for Smoking Cessation

for
Smoking Cessation, Smoking Behaviors
Location: New Haven CT, Chicago IL, Aurora CO, Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 21 - 65

Code: NCT07602699

Phase2, Recruiting
Active & Responsive

ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

for
Autosomal Dominant Polycystic Kidney Disease
Location: New Haven CT, New York NY, Bethlehem PA,
Sponsor: Calico Life Sciences LLC

Sex: All

Age: 18 - 55

Code: NCT06902558

Phase2, Recruiting
Active & Responsive

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

for
Depressive Disorder, Major
Location: New Haven CT, New York NY, Philadelphia PA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07412756

Phase3, Recruiting
Active & Responsive

Mechanistic Evaluation of Guanfacine on Drinking Behavior in Women and Men With Alcohol Use Disorders

for
Alcohol Use
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 21 - 70

Code: NCT03764098

Phase2, Recruiting
Active & Responsive

A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)

for
Insomnia
Location: New Haven CT, Providence RI, Marlton NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18 - 70

Code: NCT06655883

Phase3, Recruiting
Active & Responsive

Systems Investigation of Vaccine Responses in Aging and Frailty

for
Influenza
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 21+

Code: NCT05291676

Phase2, Recruiting
Active & Responsive

Shared Decision Making to Treat Or Prevent (STOP) HIV in Criminal Legal Involved Populations (R33)

for
Substance Use Disorders
Location: New Haven CT, Lexington KY, Dallas TX, Fort Worth TX
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT07223398

Recruiting
Active & ResponsiveNew

Sex Differences in E-Cigarette Perception

for
Nicotine Dependence, E-cigarette Use
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 21 - 44

Code: NCT07398976

Recruiting
Active & Responsive

SV2A Density Cannabis Use Disorder

for
Cannabis Use Disorder, Healthy
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18 - 70+

Code: NCT05472818

Early_phase1, Recruiting
Active & Responsive

FOG-001 in Locally Advanced or Metastatic Solid Tumors

for
Cancer, Colorectal Cancer, Solid Tumor,
Location: New Haven CT, New York NY, Philadelphia PA, Boston MA,
Sponsor: Parabilis Medicines, Inc.

Sex: All

Age: 18+

Code: NCT05919264

Phase1, Phase2, Recruiting
Active & Responsive

Cardiovascular Disease Risk in Women With Endometriosis

for
Endometriosis
Location: New Haven CT
Sponsor: Yale University

Sex: Female

Age: 18 - 45

Code: NCT03746535

Early_phase1, Recruiting
Active & Responsive

A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment

for
Primary Biliary Cholangitis
Location: New Haven CT, Manhasset NY, Cherry Hill NJ, Boston MA,
Sponsor: Ipsen

Sex: All

Age: 0+

Code: NCT06447168

Recruiting
Active & Responsive

A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

for
Primary Myelofibrosis (PMF),
Location: New Haven CT, Berkeley Heights NJ, Albany NY,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07357727

Phase3, Recruiting